GARETH LILLY PHARMA CONSULTING LIMITEDActive

Company number 09193052Private limited companyIncorporated 2014

Key figures

£359,007+15.2%
Net assets 2024/25
+19.2%
Average annual growth 2019/20–2024/25
0100 k200 k300 k400 k2019/202020/212021/222022/232023/242024/25

Like most small UK companies, GARETH LILLY PHARMA CONSULTING LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0200 k400 k600 k2019/202020/212021/222022/232023/242024/25
Filed accounts2019/20–2024/25
2020/212021/222022/232023/242024/25
Total assets226,821276,520324,264348,335403,734
Total liabilities—————
Net assets / total equity191,278242,972287,760311,600359,007
Average number of employees11111

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: GARETH LILLY PHARMA CONSULTING LIMITED

Company

GARETH LILLY PHARMA CONSULTING LIMITED is a private limited company registered with Companies House under company number 09193052. It was incorporated on 29 Aug 2014. Its status is active. The registered office is in Thatcham (RG18). Its nature of business (SIC 2007) is other business support service activities n.e.c. (82990).

Accounts

The latest accounts in the database are for 2024/25 (period ending 31 Aug 2025); the company files micro-entity accounts. Net assets were £359,007, up 15.2% on the previous year. The company had an average of 1 employee. Figures are available for 6 financial years (2019/20–2024/25).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 31 May 2027. The next confirmation statement is due by 12 Sep 2027.